bles. 10 Because the microbubbles are contained within the blood, the biological effects that are induced are mostly isolated to the walls of the blood vessel.
At frequencies used in previous studies, the skull bone distorts and defocuses the ultrasound beam. Although corrections for these distortions are possible using phasedarray transducers, 2, 8 these corrections would require a complex system and planning for each patient. As the frequency is lowered, the need for such corrections is reduced. At some point, the need for corrections is eliminated, and an acceptable ultrasound focus can be produced without the need for a complex correction scheme. An earlier report demonstrated that a frequency of approximately 250 kHz allows an ultrasound beam to be focused through the human skull to a predetermined location with minimal distortion. 8 Such a frequency would probably not be suitable for thermal ablation, because the ultrasound absorption is greatly reduced and the focal spot size is enlarged to a point at which the gain in intensity is insufficient to produce focal heating without overheating the skull surface. 25 These concerns are eliminated in the case of BBB disruption because it appears to be feasible at very low power levels. 10 Given these advantages, a substantially simpler ultrasound system could be built. These advantages are key factors to consider in the clinical use of focused ultrasound for disruption of the BBB for targeted drug delivery or molecular imaging. Unfortunately, the interaction between microbubbles and the ultrasound field is highly dependent on the frequency of the ultrasound beam. In our previous study, 9 we used a frequency of 690 kHz. Although it is possible to sonicate transcranially at that frequency, a significant focal distortion occurs due to the presence of the skull. Therefore, previously it was not known whether BBB disruption could be induced at low frequencies (200-300 kHz) without damage. The present in vivo rabbit study was conducted to explore the practicality of using low-frequency sonications for focal BBB disruption.
Materials and Methods

Study Overview
Several series of experiments were performed over the course of this study. In the first series, in each rabbit brain multiple sites in both hemispheres were targeted and a range of power levels was selected.
The tests were performed in some animals that underwent a craniotomy and in some that did not, and the aim of the experiment was to determine thresholds for BBB disruption and neuron damage. In the second series, a nanometer-sized MR imaging contrast agent was used to verify that HMW agents and nanoparticles can pass through the BBB disruption. In the third series, electron microscopy was performed using an HMW tracer. Finally, in the fourth series a survival study was performed to verify that long-term damage to the BBB did not result from the sonications. The experiments are summarized in Table 1 .
Ultrasound Equipment
The ultrasound fields were generated by a focused, air-backed, piezoelectric transducer (100-mm diameter, 80-mm radius of curvature, and 0.26-MHz frequency), which was manufactured in house. The transducer was driven by a frequency generator (model 395; WaveTek, San Diego, CA) and a radiofrequency amplifier (model 240L; ENI Inc., Rochester, NY). The acoustic power output and the focal pressure amplitude as a function of applied radiofrequency power were measured as described in a previous work. 12 The pressure was measured in water by using a calibrated membrane hydrophone (spot diameter 0.5 mm; GEC-Marconi Research Center, Chelmsford, UK) for the entire pressure amplitude range that was used. For experiments performed without a craniotomy, the effect of the rabbit skull was measured by harvesting a sample of the skull bone and then performing the hydrophone calibration through the bone. The reported values are estimates of pressure amplitudes in the brain, which are obtained by decreasing the measured water values, based on the attenuation of ultrasound that occurs as it passes 10 mm into the brain, by using an average amplitude attenuation coefficient of 5 Np/meter/MHz. 5, 6 For animals with intact skulls, this computation is furthered decreased by including the measured bone insertion loss factor of 72%. The half-intensity beam diameter and the length of the focal spot, measured with the aid of a needle hydrophone (spot diameter 0.2 mm; Precision Acoustics, Dorchester, UK), were 8 and 40 mm, respectively.
The sonications were performed while the animal was in a standard clinical MR imaging unit. The transducer was mounted onto an experimental mechanical positioning device, assembled in house, which had been placed on the table of the MR imaging unit. This system was used to move the transducer based on findings on the MR images, so that the focus was in the desired location of the brain.
Animal Preparation
Forty male New Zealand White rabbits (each weighing ~ 3-4 kg) were anesthetized by a mixture of sodium xylazine (12 mg/kg/hr; Fermenta Animal Health Co., Kansas City, MO) and ketamine (48 mg/kg/hr; Fort Dodge Laboratories, Fort Dodge, IA). In 23 of these rabbits, an ultrasound window was created in the skull by removing a piece of skull (~ 20 ϫ 20 mm) and replacing the skin over the bone window. This opening provided a more accurate estimation of the peak focal pressure amplitude in brain tissue than would be possible if the sonications had to travel through the intact skull. The experiments were performed a minimum of 10 days postoperatively. After exposure conditions for the BBB disruption had been established through the bone window, 17 rabbits were exposed to sound waves without the bone window to test the feasibility of transskull sonication.
All the rabbits were prepared in the same way. First, their uppermost cranial hair was removed with the aid of clippers and depilatory cream. The animals were placed on their backs on a water blanket containing temperature-controlled water that was circulated to maintain body temperature. The rabbit's body temperature was monitored using a Copper Constantan rectal thermocouple probe (manufactured in house using thermocouple wire [California Fine Wire Co., Grover Beach, CA]). The head of the animal was placed in a plastic holder and set in the treatment position. An open plastic bag containing degassed water provided a medium for ultrasound beam propagation from the water tank into the brain. The animals were killed between 4 hours and 5 weeks after the sonications, except for four animals used for the electron microscopy study (Table 1) . Our institutional animal committee approved all these experiments.
The Sonications
In each rabbit, the sonications were delivered to one to four sites, with the center of the focal spot located approximately 10 mm deep in the brain. The ultrasound was pulsed with a burst length of 10 msec and a repetition frequency of 1 Hz; the entire sonication lasted 20 seconds in all instances. The peak acoustic power levels during the ultrasound burst ranged from 0.09 to 4.3 W. Therefore, the maximum time-averaged acoustic power distributed over the focal spot area throughout the 20-second period was 43 mW.
Approximately 10 seconds before each sonication, a bolus of ultrasound contrast agent (Optison; Mallinckrodt, Inc., St. Louis, MO) containing albumin-coated microbubbles (mean diameter 2-4.5 ϫ 10 Ϫ6 m; concentration 5-8 ϫ 10 8 bubbles/ml) was injected into the ear vein. The injected volume was approximately 0.05 ml/kg, which was similar to the amount used in our earlier study. 10 The bolus was flushed from tubing that extended out of the MR imaging unit by injecting approximately 1 ml of saline. A delay of at least 5 minutes between sonications was used to allow clearance of most bubbles from the circulation before each sonication.
Magnetic Resonance Imaging
The MR imaging units that were used in these experiments were standard 1.5-or 3-tesla clinical systems (Signa; General Electric Medical Systems, Milwaukee, WI). A surface coil (diameter 7.5 cm in the 1.5-tesla unit and 6 cm in the 3-tesla unit) was placed under the head of the animal. A T 2 -weighted fast spin echo sequence (TR 2000 msec, TE 75 msec, four acquisitions) was used to determine the extent of the craniotomy and to choose the locations of the target sites. After the sonications, a time series of T 1 -weighted fast spin echo images (TR 500 msec, TE 15 msec, two acquisitions) was acquired and repeated after administration of an intravenous bolus (0.125 mmol/kg) of gadopentetate dimeglumine MR imaging contrast agent (MAGNEVIST; Berlex Laboratories Inc., Wayne, NJ). This agent was used to evaluate the threshold, magnitude, and duration of the resulting opening of the BBB and of any other tissue damage. For all images, the matrix was 256 ϫ 256 and the bandwidth 16 kHz. In two rabbits, a 20-nm nanoparticulate contrast agent was used instead (MION-47; Center for Molecular Imaging Research, Massachusetts General Hospital, Boston, MA, concentration 5 mg/kg). This agent was injected intravenously, either before or after the sonications, to establish the ability to deliver HMW agents into the brain.
Signal Analysis
The amount of MR contrast enhancement was evaluated at each target site by averaging the signal intensity over a 5 ϫ 5-voxel (voxel size: 0.4 mm for the 1.5-tesla imaging unit and 0.3 mm for the 3-tesla unit) region of interest. The signal was normalized to the baseline value in the region of interest before injection of the contrast agent. Control regions of nonsonicated brain tissue were selected around the sites sonicated, and the average normalized contrast enhancement observed in these control locations was subtracted from values of sonicated sites to estimate the impact of the sonications. In addition, a larger 7 ϫ 7-voxel control area was selected outside the sonicated regions, and the average SD of signal intensities of voxels in that area was calculated over the entire time series of images. If the contrast enhancement in the sonicated site was greater than the average SD value in the control area, the sonication was judged to have induced opening of the BBB. In rabbits scheduled to be killed between 4 and 5 weeks after BBB opening, the sonications were only performed on one side of the brain, and the contralateral side was used as a control location for each sonication.
Histological Findings
After the rabbits had been killed (see Table 1 for times), their brains were immediately removed. With the exception of brains used in the electron microscopy study, the rabbit brains were fixed either by transcardiac infusion of 10% buffered neutral formalin followed by immersion fixation (10% buffered formalin phosphate) or by immersion fixation alone. After fixation, the brains were embedded in paraffin and serially sectioned into 6-m slices. Every 30th section (interval 0.18 mm) was stained with H & E for histological examination.
Stains found to detect apoptotic cells and ischemic neurons were applied to sections neighboring the H & E-stained sections. We used the TUNEL technique (ApoptTag kit; Intergen Co., Purchase, NY) for the detection of DNA fragmentation and apoptotic bodies in the cells. 4 The tissue sections were counterstained with 0.5% methyl green. To visualize ischemic neurons, vanadium acid fuchsin stain and toluidine blue counterstain were applied. 26 The authors who performed the histological evaluation were blinded to the ultrasound parameters but had knowledge of the targeted sites shown in an MR image of the sonicated plane.
Electron Microscopy Study
Horseradish peroxidase (MW 40,000 D, diameter 5 nm) was used as a marker for transmission electron microscopy, 20 which was performed to evaluate the ultrastructural basis of BBB disruption in a series of four rabbit brains. Before sonication, these rabbits were each given an intraperitoneal injection of 1% promethazine (1 ml/kg; Sigma Chemical Co., St. Louis, MO) to block the histamine release induced by administration of HRP (Type VI; Sigma Chemical Co.). Trypan blue (1.5 ml/kg of a 2% solution in saline) was administered through the rabbit's ear vein to indicate macroscopically the BBB disruption. 20 The HRP (300 mg/kg dissolved in saline) was administered immediately after the trypan blue through the same vein. Two sites in each brain were then sonicated, and the animals were killed approximately 3, 20, and 60 minutes postsonication. The brains were fixed using 2.5% paraformaldehyde plus 1.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2). Fixation was performed either by transcardial perfusion (two rabbits), a method that preserves the ultrastructure but may cause artifacts by increasing vascular pressure and washing away marker from the vessels, or by immersion fixation (two rabbits), which leaves marker in the vessels and does not introduce increased pressure in the vessels, but may compromise ultrastructure fixation. Pieces of tissue excised from an area measuring approximately 0.5 mm 3 with the sonicated site in the center (visible as blue spots due to the leakage of trypan blue) and from control locations (that is, the same anatomical structure on the contralateral [nonsonicated] side of the brain) were immersed for 2 hours in the same fixative, washed in buffer, and transferred to an incubation medium containing 0.1 M Tris buffer (pH 7.4), 3,3Ј-diaminobenzidine, and hydrogen peroxide for 45 minutes at room temperature. After postfixation in 2% osmium tetroxide for 2 hours, the tissue pieces were dehydrated in ethanol, passed through propylene oxide, and embedded in Epon-Araldite. Ultrathin sections unstained or stained with uranyl acetate and lead citrate were observed with the aid of a JEM-1200EX electron microscope (JEOL, Ltd., Tokyo, Japan).
The sonicated site was correlated with the site on the MR image by localizing the focal coordinates in the imaging space prior to the sonications. The sonicated sites were identified for the histological examination by measuring the distance of the site of sonication from the midline, top, and edges of the brain in the MR images and using these measurements for the light microscopy samples. The electron microscopy samples were taken from the middle of the blue spot caused by trypan blue leakage at the site where the BBB was dis- rupted. As can be seen in Fig. 1A , the focus is so large that uncertainties in localization did not compromise the results.
Statistical Analysis
Statistical significance was tested using a paired t-test. Probability values less than 0.05 were deemed statistically significant.
Results
Brain Exposure Through Craniotomy
When selective BBB disruption occurred at the target site, it was visible on T 1 -weighted MAGNEVIST-enhanced images as a hyperintense spot (Fig. 1A) . Over time, the magnitude of the disruption decreased (Fig. 2) , a finding suggesting recovery of BBB integrity. The disruption was clearly detected at exposure levels greater than 0.2 MPa, and the magnitude of contrast enhancement increased as a function of the pressure amplitude (Fig. 3 upper) . None of the locations sonicated at 0.2 MPa demonstrated focal contrast enhancement greater than the SD of the signal in normal brain, whereas 100% of the sites sonicated at 0.3 MPa exhibited such an enhancement (Fig. 3 lower) . No enhancement in sites sonicated without Optison was observed, even when the sonication had been induced at the maximum pressure amplitude value tested (0.9 MPa).
The histological evaluation performed after 4 to 24 hours of survival did not show any effects on blood vessels or brain tissue at pressure amplitudes at 0.3 MPa (Fig. 4) . At 0.4 MPa, most locations (80%) demonstrated vascular effects ranging from a few scattered erythrocytes to multiple petechial extravasations (Fig. 5A & B) . Some of the extravasations were accompanied by an enlarged perivascular space (Fig. 5C) , mild damage to the parenchyma including vacuolization of the neuropil surrounding affected microvessels, and minor neutrophil activation. The volume of such affected regions was limited to the immediate perivascular space. No area containing multiple ischemic or apoptotic neurons was found, but occasional, individual apoptotic cells were observed in a few locations (Fig. 5D-F) , with one site having a cluster of six apoptotic cells that most likely were glial cells and ECs.
In the two rabbits sonicated and imaged with the aid of MION-47, focal enhancement was also observed, demonstrating that the ultrasound-induced BBB disruption allowed nanoparticles to enter the brain. Enhancement was observed for sonications performed before and after the MION-47 injection (Fig. 6) . similar amount of contrast enhancement to brains sonicated through a skull window (Fig. 3 upper) , and the percentage of sites demonstrating BBB disruption was similar to that found following sonications through the skull window, verifying the previous result (Fig. 3 lower) .
Sonications Through the Skull
Survival Experiments
First Experiment. The animals examined between 7 and 9 days after BBB disruption had all received sonications through the intact skull either at a single location or at four overlapping sites in one hemisphere at intrabrain acoustic pressure amplitudes of 0.3 or 0.4 MPa. The other hemisphere was not sonicated and acted as an internal control.
All the sites sonicated displayed evidence of BBB opening on contrast-enhanced MR images immediately after sonication. In one location (sonicated at 0.3 MPa), the enhancement could be visually detected in subtracted contrast-enhanced images, but it did not meet the criterion used for opening of the BBB (that is, an average signal increase equal to or larger than one SD of the noise in the control volume). Histological analysis of brain tissue performed in four of the six brains showed no obvious damage to these brains, except for a few groups of erythrocytes outside blood vessels.
Second Experiment. In six of the animals examined 4 to 5 weeks after BBB disruption the brains were sonicated at 0.3 MPa and in three at 0.4 MPa. Sites of the brain that had been sonicated at either of these pressure amplitudes showed selective enhancement after sonications when compared with control locations. After 4 to 5 weeks of survival, however, no difference in the MR imaging signal was detected between sonicated and control locations ( Table 2) .
The histological findings indicated no damage to the neurons (Fig. 1) . Hemosiderin was found in one of nine locations that had been sonicated at 0.4 MPa, possibly indicating that a few red blood cells had leaked into the tissue after the sonication (Fig. 7) . No ischemic or apoptotic cells were detected in sonicated sites.
Electron Microscopy Study
In control (nonsonicated) areas of the brain, the HRP reaction product appeared in endosome-like vacuoles in the cytoplasm of the vessels' ECs and in a few caveolae. No HRP was present in interendothelial clefts. There was no positive reaction in the basement membrane, pericytes, or neuropil (Fig. 8A) .
In animals killed 3 or 20 minutes after sonication, the ultrastructural localization of the tracer was similar to those described earlier, that is, in the endosomes and a few caveolae of ECs. However, an enhanced number of caveolae filled with HRP reaction product were present in the ECs of some vessels.
In brain tissue samples acquired 60 minutes after sonication, the staining reaction to HRP was positive in vacuoles and in caveolae, predominantly at the abluminal zone of the ECs, in the basement membrane, and in the interstitium of the neuropil; the latter appeared to be flooded with tracer (Fig. 8B) . Some interendothelial clefts were filled with HRP reaction product, demonstrating opened paracellular passageways (Fig. 8C) . Numerous tracer-positive caveolae were observed in pericytes and in the cytoplasm of both arterioles and venules in muscle cells. There were extravasations of small red blood cells in three of eight sites examined using electron microscopy. No other damage to blood vessels or nerve cells was seen, and the ultrastructure of the tissue appeared fully preserved.
The results show that the BBB can be disrupted for blood-borne macromolecules such as HRP (MW 40 kD) by ultrasound at the parameters applied. Leakage of tracer was manifested by both transcellular passage via caveolae and cytoplasmic vacuolar structures, and through opened intercellular junctions in capillaries, small arterioles, and venules.
Discussion
The results of this study provide further support for the hypothesis that focused ultrasound can be used to disrupt the BBB locally for the delivery of large molecules into the brain without inducing neuronal damage. Perhaps even more importantly, the findings of our experiments demonstrate sonication parameters that consistently resulted in BBB disruption without extravasations of red blood cells, which were often seen following sonications at higher frequencies and, to a lesser amount, at 0.4 MPa at the frequency used in this study. These results and those of earlier survival experiments 28 should answer most concerns about safety expressed by others in the past. 19 The results given here extend the usable frequency range to approximately 260 kHz, a frequency that allows focusing of the ultrasound beam through the intact skull without any patient-specific corrections. 11 Thus, a relatively simple, mechanically positioned transducer could be used for the treatment. Alternatively, because the use of such a low frequency makes it easier to create a phased array transducer (because the element size can be larger), electrical beam steering is more manageable, and one could take advantage of electrical focusing of the beam in the system design.
29
Although the duration of BBB disruption was not extensively investigated in this study, our results show that the defect is almost completely closed 5 hours after sonication. After 4 to 5 weeks of survival, no evidence of BBB disruption was detected in any sonicated site. This finding is in agreement with the results of previous experiments conducted at 1.63 MHz 10,28 and 0.69 MHz, 9 in which the duration of BBB disruption was more extensively investigated. Therefore, the method provides a time window that starts to close a few hours after sonication. If a longer disruption or multiple deliveries over time are needed, sonications can be repeated. Nevertheless, the impact of multiple sonications on brain tissue needs to be further investigated before such studies can be performed in humans.
This BBB disruption method involves the use of preformed microbubbles in the blood stream. Others investigators have shown that ultrasound alone can be used to disrupt the BBB around thermally induced lesions 17, 23 or when high-pressure amplitudes are used to induce cavitation. 18, 27 Neither of these methods has thus far been improved to a degree that would allow the BBB to be disrupted consistently without damage to brain tissue. Ultrasound has also been shown to increase the permeability of the blood vessel wall to large molecules in other organs with 15 and without 3 the use of microbubbles. All these studies indicate that image-guided focused ultrasound has the potential for targeting local drug and gene delivery. This ability may permit the delivery of an increased local dosage with reduced systemic effects.
In an earlier study in which ultrasound exposures at a higher frequency (2 MHz) were used without preformed gas bubbles, the findings indicated that the mechanism for ultrasound-induced BBB disruption was associated with widening of the tight junctions. 18 Using our method, earlier electron microscopy studies showed that tight junctions sometimes provide passage for a marker molecule, but that transport in vacuoles through the EC walls was also present. 24 Those studies were performed at frequencies of 1.63 and 0.69 MHz, and their findings are consistent with what we found at 260 kHz. Due to the low time-averaged power associated with these exposures (maximum time-averaged acoustic power 0.043 W) and the lack of temperature rise observed by MR imaging thermometry in an earlier study, 12 it is highly unlikely that bulk temperature elevation was the mechanism for the BBB disruption. Clearly, changes in BBB integrity are associated with ultrasound interaction with preformed gas bubbles. However, the exact nature of the mechanism that induces the BBB disruption is not clear. There are several candidates. The bubbles may collapse in the ultrasound field and generate microscopic hot spots, microjets, or shock waves that induce thermal or mechanical damage to the capillary wall. Another possibility is that the bubbles cause microstreaming, which triggers a receptorbased response in ECs that opens the BBB. The bubbles may expand enough in the capillary to stretch the capillary wall, opening the tight junctions. If an expanding bubble filled the whole capillary, it could cause a temporary ischemic reaction with associated BBB disruption. 16 Finally, the cyclic radiation pressure "experienced" by the bubbles may
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Focal blood-brain barrier disruption 453 FIG. 8. Electron micrographs. A: Cross-section of a brain capillary from a nonsonicated region. The darkly stained HRP reaction product is localized in several endosome-like vacuoles (arrows) in the cytoplasm of ECs. No reaction product is seen beyond the endothelial lining, in the basement membrane (b), pericyte (P), or neuropil (NP). A red blood cell (RBC) in the lumen (L) of the vessel also displays a dark stain due to the peroxidase activity of the hemoglobin. B: Another microvessel profile in a specimen obtained from the sonicated location 60 minutes after ultrasound exposure. The reaction product is again seen in EC vacuoles and also outside the endothelium in the basement membrane, which looks heavily infiltrated with HRP (some indicated with arrowheads), and everywhere in the interstitial spaces of neuropil (the dark zones, some of which are indicated by arrows). C: A portion of capillary wall obtained from the same location as the tissue shown in the above panels, at a higher magnification. Peroxidase has entered a cleft (black arrows) between two ECs, passed to the basement membrane, and infiltrated the interstitial space (white arrows) among myelinated axons (ax). Caveolae (arrowheads) filled with HRP are seen in the ECs and pericyte at the luminal, middle, and basal parts of the cell, suggesting their possible involvement in the transcellular transport of the tracer. a = astrocytic end feet; ax = cross-sections and longitudinal sections of myelinated axons; N = cytoplasm of an adjacent neuron.
trigger the BBB opening in a way similar to that observed with increased blood pressure. 13 More work needs to be done to determine the exact mechanism.
Conclusions
We have demonstrated that focal BBB disruption can be produced at sonication parameters available in a simple ultrasound system, which can easily produce a focus of BBB disruption through the intact skull. This finding may have a large impact in brain research, diagnosis, and therapy.
